All In Biotech

Free tool

FAERS Monitor: Plegisol In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018608 or its brand name (Plegisol In Plastic Container, Calcium Chloride, Magnesium Chloride, Potassium Chloride, Sodium Chloride). Reports on generic versions are filed under their own applications.

Reports

16

Serious

11

69% of reports

Hospitalization

4

Death reported

4

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective5
  • cerebrovascular accident3
  • renal failure3
  • injury2
  • multiple sclerosis2
  • peripheral vascular disorder2
  • renal injury2
  • acute kidney injury1
  • acute respiratory failure1
  • anaemia1
  • anaphylactic reaction1
  • anxiety1
  • aortic valve incompetence1
  • asthenia1
  • atrial fibrillation1

Reports by year received

View as table
YearReports
20041
20052
20113
20122
20131
20193
20223
20251

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,143 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
peripheral vascular disorder2510.5139.6571
aortic valve incompetence1309.046.376
renal injury288.524.297
acute respiratory failure168.310.216
multiple sclerosis255.015.059
injury237.410.239
renal failureSignal329.710.757
anaphylactic reaction123.83.65
cerebrovascular accidentSignal323.38.444
atrial fibrillation113.52.02
acute kidney injury18.61.31
anaemia16.91.01
drug ineffectiveSignal55.02.413
anxiety14.60.70
asthenia13.50.50

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.